These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17087191)
1. [Growth factors and the hystologic picture of the liver in chronic viral hepatitis and hepatic cirrhosis]. Iagoda AB; Koroĭ PV; Geĭvandova NI; Nikitina OA; Kastornaia IV Klin Med (Mosk); 2006; 84(8):44-7. PubMed ID: 17087191 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [TBL] [Abstract][Full Text] [Related]
3. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model. Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207 [TBL] [Abstract][Full Text] [Related]
4. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B. Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870 [TBL] [Abstract][Full Text] [Related]
5. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B]. Guo JC; Bao JF; Chen QW; Li XO; Shi JP; Lou GQ; Shi WZ; Xun YH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):354-7. PubMed ID: 19469173 [TBL] [Abstract][Full Text] [Related]
6. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between serum TGF beta-1 with chronic hepatitis B involving in liver cell function and liver biopsy fibrosis]. Sun Y; Xuan S; Xin Y; Lu W; Chu L Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):221-2. PubMed ID: 12113686 [No Abstract] [Full Text] [Related]
9. [The effect of serum TGFb1 of patients with chronic hepatitis B in liver fibrosis formation]. Liu F; Li B; Nan Y Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):196-8. PubMed ID: 10715784 [TBL] [Abstract][Full Text] [Related]
10. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis. Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211 [TBL] [Abstract][Full Text] [Related]
11. [Histological changes in 20 hepatic fibrosis patients with chronic hepatitis B after recombinant human interferon-gamma treatment]. Du X; Weng H; Cai W Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):273-5. PubMed ID: 11676870 [TBL] [Abstract][Full Text] [Related]
12. [Detection of serum free insulin-like growth factor 1 in patients with chronic viral hepatitis]. Lou M; Song N; Jin X; Luo SQ; Wang JJ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):291-2. PubMed ID: 11986710 [TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67, transforming growth factor beta1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases. Piekarska A; Piekarski J; Omulecka A; Szymczak W; Kubiak R J Gastroenterol Hepatol; 2006 Apr; 21(4):700-10. PubMed ID: 16677156 [TBL] [Abstract][Full Text] [Related]
14. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis]. Zhang LF; Tian XX; Wang CF Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311 [TBL] [Abstract][Full Text] [Related]
16. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B]. Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633 [TBL] [Abstract][Full Text] [Related]
17. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
18. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
19. [The relationship between hepatic expression, serum level of TGFbeta1 and the hepatic fibrosis in patients with viral hepatitis]. Li BS; Yan WZ; Liu JX; Zhen Z; Kong L; Liu F Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):271-3. PubMed ID: 15161500 [TBL] [Abstract][Full Text] [Related]
20. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage? Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]